Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company (KFSHI), posted on X:
“The Rapidly Evolving AML Treatment Landscape.
From FLT3 inhibitors to menin inhibitors, FDA approvals have transformed AML management over the last decade. Here’s a timeline of milestones shaping the future of care.”
